Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland

COVID-19 vaccinations are essential to mitigate the pandemic and prevent severe SARS-CoV-2 infections. However, the serum antibody levels in vaccinated individuals gradually decrease over time, while SARS-CoV-2 is undergoing an evolution toward more transmissible variants, such as B.1.617.2, ultimat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Piotr Rzymski, Barbara Poniedziałek, Andrzej Fal
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	COVID-19 vaccine booster dose vaccine hesitancy mRNA vaccines vector vaccines SARS-CoV-2 Medicine R
Acceso en línea:	https://doaj.org/article/95df33d62e54484fac64bf6a5c7eae1b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:95df33d62e54484fac64bf6a5c7eae1b
record_format	dspace
spelling	oai:doaj.org-article:95df33d62e54484fac64bf6a5c7eae1b2021-11-25T19:10:56ZWillingness to Receive the Booster COVID-19 Vaccine Dose in Poland10.3390/vaccines91112862076-393Xhttps://doaj.org/article/95df33d62e54484fac64bf6a5c7eae1b2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1286https://doaj.org/toc/2076-393XCOVID-19 vaccinations are essential to mitigate the pandemic and prevent severe SARS-CoV-2 infections. However, the serum antibody levels in vaccinated individuals gradually decrease over time, while SARS-CoV-2 is undergoing an evolution toward more transmissible variants, such as B.1.617.2, ultimately increasing the risk of breakthrough infections and further virus spread. This cross-sectional online study of adult Poles (<i>n</i> = 2427) was conducted in September 2021 (before a general recommendation to administer a booster COVID-19 vaccine dose in Poland was issued) to assess the attitude of individuals who completed the current vaccination regime toward a potential booster dose of the COVID-19 vaccine and identify potential factors that may influence it. Overall, 71% of participants declared willingness to receive a booster COVID-19 dose, with a low median level of fear of receiving it of 1.0 (measured by the 10-point Likert-type scale), which was increased particularly in those having a worse experience (in terms of severity of side effects and associated fear) with past COVID-19 vaccination. The lowest frequency of willingness to receive a booster dose (26.7%) was seen in the group previously vaccinated with Ad26.COV2.S. The majority of individuals vaccinated previously with mRNA vaccines wished to receive the same vaccine, while in the case of AZD1222, such accordance was observed only in 9.1%. The main reasons against accepting a booster COVID-19 dose included the side effects experienced after previous doses, the opinion that further vaccination is unnecessary, and safety uncertainties. Women, older individuals (≥50 years), subjects with obesity, chronic diseases, and pre-vaccination and post-vaccination SARS-CoV-2 infections, and those with a history of vaccination against influenza were significantly more frequently willing to receive a booster COVID-19 dose. Moreover, the majority of immunosuppressed individuals (88%) were willing to receive an additional dose. The results emphasize some hesitancy toward potential further COVID-19 vaccination in the studied group of Poles and indicate the main groups to be targeted with effective science communication regarding the booster doses.Piotr RzymskiBarbara PoniedziałekAndrzej FalMDPI AGarticleCOVID-19 vaccinebooster dosevaccine hesitancymRNA vaccinesvector vaccinesSARS-CoV-2MedicineRENVaccines, Vol 9, Iss 1286, p 1286 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 vaccine booster dose vaccine hesitancy mRNA vaccines vector vaccines SARS-CoV-2 Medicine R
spellingShingle	COVID-19 vaccine booster dose vaccine hesitancy mRNA vaccines vector vaccines SARS-CoV-2 Medicine R Piotr Rzymski Barbara Poniedziałek Andrzej Fal Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
description	COVID-19 vaccinations are essential to mitigate the pandemic and prevent severe SARS-CoV-2 infections. However, the serum antibody levels in vaccinated individuals gradually decrease over time, while SARS-CoV-2 is undergoing an evolution toward more transmissible variants, such as B.1.617.2, ultimately increasing the risk of breakthrough infections and further virus spread. This cross-sectional online study of adult Poles (<i>n</i> = 2427) was conducted in September 2021 (before a general recommendation to administer a booster COVID-19 vaccine dose in Poland was issued) to assess the attitude of individuals who completed the current vaccination regime toward a potential booster dose of the COVID-19 vaccine and identify potential factors that may influence it. Overall, 71% of participants declared willingness to receive a booster COVID-19 dose, with a low median level of fear of receiving it of 1.0 (measured by the 10-point Likert-type scale), which was increased particularly in those having a worse experience (in terms of severity of side effects and associated fear) with past COVID-19 vaccination. The lowest frequency of willingness to receive a booster dose (26.7%) was seen in the group previously vaccinated with Ad26.COV2.S. The majority of individuals vaccinated previously with mRNA vaccines wished to receive the same vaccine, while in the case of AZD1222, such accordance was observed only in 9.1%. The main reasons against accepting a booster COVID-19 dose included the side effects experienced after previous doses, the opinion that further vaccination is unnecessary, and safety uncertainties. Women, older individuals (≥50 years), subjects with obesity, chronic diseases, and pre-vaccination and post-vaccination SARS-CoV-2 infections, and those with a history of vaccination against influenza were significantly more frequently willing to receive a booster COVID-19 dose. Moreover, the majority of immunosuppressed individuals (88%) were willing to receive an additional dose. The results emphasize some hesitancy toward potential further COVID-19 vaccination in the studied group of Poles and indicate the main groups to be targeted with effective science communication regarding the booster doses.
format	article
author	Piotr Rzymski Barbara Poniedziałek Andrzej Fal
author_facet	Piotr Rzymski Barbara Poniedziałek Andrzej Fal
author_sort	Piotr Rzymski
title	Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
title_short	Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
title_full	Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
title_fullStr	Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
title_full_unstemmed	Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
title_sort	willingness to receive the booster covid-19 vaccine dose in poland
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/95df33d62e54484fac64bf6a5c7eae1b
work_keys_str_mv	AT piotrrzymski willingnesstoreceivetheboostercovid19vaccinedoseinpoland AT barbaraponiedziałek willingnesstoreceivetheboostercovid19vaccinedoseinpoland AT andrzejfal willingnesstoreceivetheboostercovid19vaccinedoseinpoland
_version_	1718410231312023552

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland

Ejemplares similares